Buy
|
Original-Research: mVISE AG - from NuWays AG
Classification of NuWays AG to mVISE AG
mVISE free of bank liabilities going forward Topic: Under the lead of Finanzhaus Main Tauber (FHMT), a consortium of investors will assume all bank liabilities of mVISE (€ 2.3m as of H1’24) as of January 31, as part of a refinancing. The consortium, which is represented on the Supervisory Board by Stefan Träumer, currently holds c. 2% of the shares in mVISE and has reiterated its intention of increasing their commitment and hereby intensifying their cooperation/involvement. In our view, this has to be seen as positive news for the company, as it documents the confidence of the consortium in the investment case and the successful transformation (for more detail see our initiation) of mVISE. Moreover, all investors are now on the same side of the table, having eliminated banks out of the equation, which is seen to facilitate future financing and refinancing. Mind you, the company aims to pursue a Buy & Build approach going forward in order to become a serious competitor for larger, mostly anglo saxon competitors like Avaya or Genesis in the DACH region. Besides this, the company is going to release its FY report in March. After a strong start in the year with an adj. EBITDA of € 0.5m, we expect the company to also show strong figures for H2. Despite an expected decline of the top-line (eNuW: € 9.4m), which is explained by significant staff reductions in connection with the current efficiency program, EBITDA looks set to increase to € 1.2m, implying a margin of 13.0% (+4.2pp yoy). The strong margin expansion should be mainly driven by the acquisition of opcyc (60% EBITDA margin at € 1.7m sales) as well as significant operational improvements leading to increased utilization rates. Overall, this is currently not adequately reflected in share price, in our view, given a valuation of 8.9x EV/ EBTIDA FY25e (6.7x FY26e). We hence reiterate BUY with an unchanged € 1.40 PT based on DCF. You can download the research here: http://www.more-ir.de/d/31693.pdf For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||
2077513 30.01.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.